Conditions of the nervous system are some of the most complex to understand and treat—posing some of the most difficult scientific challenges of our time. We are up for those challenges.
Genentech is committed to supporting people affected by neurological disorders. As a member of the Roche Group, we have the technology and scientific insights to discover and develop breakthrough medicines for the most common and rare neurological conditions so that we can slow, or even one day reverse, the progression of disease.
But our commitment goes beyond our medicines. Our teams have also been supporting new research through grants, partnering with communities to uncover and test new clinical endpoints, and identifying new digital technologies to diagnose and monitor disease progression.
With our partners across advocacy, academia, industry and the broader healthcare community, we continue to push the boundaries of scientific understanding to achieve clinical advancements. Together, we hope to solve some of the greatest challenges that have eluded the neuroscience community for generations.